The sensitivity of medicare data for identifying incident cases of invasive melanoma (United States)

Cancer Causes and Control

Volumn 15, Issue 2, 2004, Pages 179-184

  Barzilai, David A ^a   Koroukian, Siran M ^a   Neuhauser, Duncan ^a   Cooper, Kevin D ^a   Rimm, Alfred A ^a   Cooper, Gregory S ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Feasibility studies; Medicare; Melanoma; SEER Program; Sensitivity and specificity; Validation studies

Indexed keywords

AGED; ARTICLE; CALCULATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MELANOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED STATES; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INSURANCE CLAIM REPORTING; MALE; MEDICARE; MELANOMA; NEOPLASM INVASIVENESS; POPULATION SURVEILLANCE; SEER PROGRAM; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 1842534555     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000019504.74553.32     Document Type: Article

References (30)

1. Harrison RA, Haque AU, Roseman JM, Soong SJ (1998) Socioeconomic characteristics and melanoma incidence. Ann Epidemiol 8(5): 327-333.
2. Dennis LK, White E, Lee JA (1993) Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 4(2): 93-100.
3. Dennis LK (1999) Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135(3): 275-280.
4. Jemal A, Devesa SS, Hartge P, Tucker MA (2001) Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93(9): 678-683.
5. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl): IV-3-18.
6. Ries LAG, Eisner MP, Kosary CL, et al. (2003) SEER Cancer Statistics Review, 1975-2000. Bethesda, MD: National Cancer Institute.
7. Nattinger AB, McAuliffe TL, Schapira MM (1997) Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J Clin Epidemiol 50(8): 939-945.
8. Gornick ME, Warren JL, Eggers PW, et al. (1996) Thirty years of Medicare: impact on the covered population. Health Care Financ Rev 18(2): 179-237.
9. Lauderdale DS, Furner SE, Miles TP, Goldberg J (1993) Epidemiologic uses of Medicare data. Epidemiol Rev 15(2): 319-327.
10. Virnig BA, McBean M (2001) Administrative data for public health surveillance and planning. Ann Rev Public Health 22: 213-230.
11. McBean AM, Warren JL, Babish JD (1994) Measuring the incidence of cancer in elderly Americans using Medicare claims data. Cancer 73(9): 2417-2425.
12. Cooper GS, Yuan Z, Landefeld CS, Johanson JF, Rimm AA (1995) A national population-based study of incidence of colorectal cancer and age. Implications for screening in older Americans. Cancer 75(3): 775-781.
13. Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS (1992) Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326(17): 1102-1107.
14. Cooper GS, Yuan Z, Landefeld CS, Rimm AA (1996) Surgery for colorectal cancer: race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health 86(4): 582-586.
15. Mark DH (1994) Mortality of patients after radical prostatectomy: analysis of recent Medicare claims. J Urol 152(3): 896-898.
16. McBean AM, Babish JD, Warren JL (1993) Determination of lung cancer incidence in the elderly using Medicare claims data. Am J Epidemiol 137(2): 226-234.
17. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG (1993) Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 31(8): 732-748.
18. Moulton G (1998) Database provides window on applications of treatments. J Natl Cancer Inst 90(24): 1865-1866.
19. Cooper GS, Yuan Z, Stange KC, Dennis LK, Amini SB, Rimm AA (1999) The sensitivity of Medicare claims data for case ascertainment of six common cancers. Med Care 37(5): 436-444.
20. McClish DK, Penberthy L, Whittemore M, et al. (1997) Ability of Medicare claims data and cancer registries to identify cancer cases and treatment. Am J Epidemiol 145(3): 227-233.
21. Joseph AK, Mark TL, Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 27(11): 955-959.
22. Chen JG, Fleischer AB, Jr., Smith ED, et al. (2001) Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 27(12): 1035-1038.
23. Riley GF, Potosky AL, Lubitz JD, Brown ML (1994) Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health 84(10): 1598-1604.
24. Fisher ES, Whaley FS, Krushat WM, et al. (1992) The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health 82(2): 243-248.
25. Karagas MR, Thomas DB, Roth GJ, Johnson LK, Weiss NS (1991) The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State. Am J Epidemiol 133(1): 58-62.
26. Koh HK, Clapp RW, Barnett JM, et al. (1991) Systematic underreporting of cutaneous malignant melanoma in Massachusetts. Possible implications for national incidence figures. J Am Acad Dermatol 24(4): 545-550.
27. Merlino LA, Sullivan KJ, Whitaker DC, Lynch CF (1997) The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. J Am Acad Dermatol 37(4): 578-585.
28. Koh HK, Geller A, Miller DR, Clapp RW, Lew RA (1992) Underreporting of cutaneous melanoma in cancer registries nationwide. J Am Acad Dermatol 27(6 Pt 1): 1035-1036.
29. Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL (2002) Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40(8 Suppl): IV-19-25.
30. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL (2002) Use of SEER-Medicare data for measuring cancer surgery. Med Care 40(8 Suppl): IV-43-8.